^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Merkel Cell Carcinoma |
| Regimen: | CAV (cyclophosphamide + pegylated liposomal doxorubicin + vincristine) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Merkel Cell Carcinoma: Preferred regimen...Useful in certain circumstances as clinical judgment dictates for patients with contraindications to checkpoint immunotherapy…Cyclophosphaide, doxorubicin (or epirubicin), and vincristine (CAV)
